Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors

Autor: Allan Tsung, Anup S. Shetty, Richard Tsai, Amir A. Borhani, Kathryn J. Fowler, Maverick LeBlanc, Tyler J. Fraum, Daniel R. Ludwig, Alessandro Furlan, Amber Salter, Muhammad Naeem, Roberto Cannella
Přispěvatelé: Fraum T.J., Cannella R., Ludwig D.R., Tsai R., Naeem M., LeBlanc M., Salter A., Tsung A., Shetty A.S., Borhani A.A., Furlan A., Fowler K.J.
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Male
medicine.medical_specialty
Carcinoma
Hepatocellular

Contrast Media
Target population
Logistic regression
Gastroenterology
Liver neoplasm
030218 nuclear medicine & medical imaging
Liver cirrhosi
Diagnosis
Differential

Cholangiocarcinoma
03 medical and health sciences
0302 clinical medicine
hepatocellular
Risk Factors
Internal medicine
Bile duct neoplasm
Humans
Medicine
Single-Blind Method
Radiology
Nuclear Medicine and imaging

Aged
Retrospective Studies
Neuroradiology
medicine.diagnostic_test
business.industry
Liver Neoplasms
Carcinoma
Retrospective cohort study
Interventional radiology
General Medicine
Middle Aged
medicine.disease
Magnetic Resonance Imaging
digestive system diseases
Exact test
Logistic Models
030220 oncology & carcinogenesis
Hepatocellular carcinoma
Female
Radiology
Tomography
X-Ray Computed

business
Settore MED/36 - Diagnostica Per Immagini E Radioterapia
Arterial phase
Popis: To determine whether the LI-RADS imaging features of primary liver carcinomas (PLCs) other than hepatocellular carcinoma (non-HCC PLCs) differ between patients considered high risk (RF+) versus not high risk (RF−) for HCC and to compare rates of miscategorization as probable or definite HCC between the RF+ and RF− populations. This retrospective study included all pathology-proven non-HCC PLCs imaged with liver-protocol CT or MRI from 2007 to 2017 at two liver transplant centers. Patients were defined per LI-RADS v2018 criteria as RF+ or RF−. Two independent, blinded readers (R1, R2) categorized 265 lesions using LI-RADS v2018. Logistic regression was utilized to assess for differences in imaging feature frequencies between RF+ and RF− patients. Fisher’s exact test was used to assess for differences in miscategorization rates. Non-HCC PLCs were significantly more likely to exhibit nonrim arterial phase hyperenhancement (R1: OR = 2.94; R2: OR = 7.09) and nonperipheral “washout” (R1: OR = 3.65; R2: OR = 7.69) but significantly less likely to exhibit peripheral “washout” (R1: OR = 0.30; R2: OR = 0.10) and delayed central enhancement (R1: OR = 0.18; R2: OR = 0.25) in RF+ patients relative to RF− patients. Consequently, non-HCC PLCs were more often miscategorized as probable or definite HCC in RF+ versus RF− patients (R1: 23.3% vs. 3.6%, p
Databáze: OpenAIRE